FierceBiotechOriginal article
{"a":[{"_":"Lilly puts up $100M, plus billions on the backend, to form 5-target deal with InnoCare","$":{"href":"/biotech/eli-lilly-puts-100m-plus-billions-backend-form-5-target-deal-innocare","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
Eli Lilly committed $100 million upfront and near-term payments to InnoCare Pharma for a five-target drug discovery collaboration, with potential milestone payments up to $3.25 billion.
Importance:7/10
Sentiment:
0.60
partnershipdrug discoverymilestone paymentscollaboration
Related Companies
Read the original article
Published by FierceBiotech on September 24, 2026 2:39 AM
